Cancer Research

SAN DIEGO, October 8 /PRNewswire/ -- - Company Announces Corporate Restructuring to Focus on Strategic Alliances and M&A Nventa Biopharmaceuticals Corporation (TSX: NVN), a company developing innovative therapeutics for the treatment of viral infections and cancer, today provided an update on its ongoing development programs. The company also announced that it will initiate a corporate restructuring that will extend the company's financial resources to pursue near-term corporate development opportunities, sale of specific programs, M&A and alternative financial arrangements to…

Chances are that if you've even stepped near a health foods store in the past few months, you've heard tales of an amazing imported fruit claimed to be one of the greatest super-foods of our time; the Brazilian Acai/Açaí (ah-sigh-ee) berry. Rich in antioxidants and packed full of health benefits, the tiny berry sparked an obsession in the health food world, even without significant laboratory testing. Brazilian Acai berries. Photo Credit: Black Diamond University  The Acai is the size of a blueberry but contains twice the antioxidants of its cousin and 10 times more than red grapes…

SAN DIEGO, October 8 /PRNewswire/ -- - Findings Confirm Potency of Poly-ICR as Vaccine Adjuvant Nventa Biopharmaceuticals Corporation (TSX: NVN) today presented positive data from preclinical studies using its proprietary Toll-like Receptor 3 agonist, Poly IC-Poly Arginine (Poly-ICR), at the World Vaccine Congress 2008 in Lyon, France. Study results demonstrated Poly-ICR to be a potent vaccine adjuvant targeting the Toll-like Receptor 3 (TLR3) pathway. Data showed that Poly-ICR, in combination with model antigens, elicits strong anti-target antibody and CD8 T-cell immune responses. These…

The Senecavirus is a "new" virus, discovered several years ago by Neotropix Inc., a biotech company in Malvern, Pennsylvania. It was at first thought to be a laboratory contaminant, but researchers found it was a pathogen, now believed to originate from cows or pigs. Further investigation found that the virus was harmless to normal human cells, but could infect certain solid tumors, such as small cell lung cancer, the most common form of lung cancer. Scientists at Neotrophix say that, in laboratory and animal studies, the virus demonstrates cancer-killing specificity that is 10,000 times…

The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry for 2008 jointly to Japanese citizen Osamu Shimomura, of Marine Biological Laboratory (MBL), Woods Hole, MA, and Boston University Medical School along with Americans Martin Chalfie, Columbia University, New York and Roger Y. Tsien, University of California, San Diego, La Jolla, "for the discovery and development of the green fluorescent protein, GFP". Glowing proteins – a guiding star for biochemistry The remarkable brightly glowing green fluorescent protein, GFP, was first observed in the beautiful…

Recent studies indicate that infusing hearts with stem cells taken from bone marrow could improve cardiac function after myocardial infarction - tissue damage that results from a heart attack. But in a recent systematic review, Cochrane Researchers concluded that more clinical trials are needed to assess the effectiveness of stem cell therapies for heart patients, as well as studies to establish how these treatments work. In a heart attack, blocked arteries can cut off the blood supply to areas of heart tissue. This leads to myocardial infarction - severe tissue damage caused by lack of…

Even small amounts of fluoride consumed from tap water can damage your bones, teeth, brain, disrupt your thyroid function, lower IQ and/or cause cancer, according to evidence revealed in a groundbreaking 2006 National Research Council (NRC) fluoride report produced by a panel of experts who reviewed hundreds of published fluoride studies. Fluoridation cheerleaders such as the American Dental Association (ADA) and the US Centers for Disease Control (CDC) claim this report has nothing to do with fluoridation (the addition of fluoride chemicals into public water supplies). However, because of…

KVISTGÅRD, Denmark, October 7 /PRNewswire/ -- - 125 Patient, Prospective Randomized Placebo-Controlled Phase II Study Shows Statistically Significant Improved Overall Survival KVISTGÅRD, Denmark, October 7 /PRNewswire/ -- Bavarian Nordic has now evaluated the mature phase II data from the therapeutic prostate cancer vaccine candidate PROSTVAC(TM) that had been obtained as part of the recently entered partnership with the National Cancer Institute (NCI) in the US. The results from the Phase II prospective randomized placebo-controlled study of 125 patients with advanced prostate cancer after…

VENLO, Netherlands, October 6 /PRNewswire/ -- - QIAGEN's HPV testing technologies are a successful commercialization of the Nobel Prize in Medicine winner's research The Nobel Prize-winning discovery of the causal link between human papillomavirus (HPV) and cervical cancer has spurred lifesaving prevention technologies -- such as HPV testing and HPV vaccines -- that are helping to eradicate cervical cancer globally. The Nobel Prize Committee today announced that Professor Harald zur Hausen at the German Cancer Research Center in Heidelberg will receive this year's Nobel Prize in Medicine/…

BILLERICA, Massachusetts, October 6 /PRNewswire/ -- - Novel technology opens the door to the understanding of and possible treatments for obesity, diabetes, ageing and cancer Seahorse Bioscience today announced the release of the first ever analytical instrument for the kinetic measurement of mitochondrial oxygen consumption and cytoplasmic glycolysis in cells in a 96 well microplate. For the past 75 years tools for measuring cellular bioenergetics have been relatively unchanged since Warburg designed the Warburg Apparatus in 1932 and Leland Clark invented the Clark oxygen electrode in 1959…